January 4, 2024 Comments Off on New patent for Mylan Ireland drug YUPELRI Posted in: Patent Added Annual Drug Patent Expirations for YUPELRI Yupelri is a drug marketed by Mylan Ireland Ltd and is included in one NDA. It is available from one supplier. There are eighteen…
The post New patent for Mylan Ireland drug YUPELRI appeared first on DrugPaten…
January 4, 2024 Comments Off on New patent expiration for Novartis drug TASIGNA Posted in: Uncategorized
Annual Drug Patent Expirations for TASIGNA Tasigna is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent expiration for Novartis drug TASIGNA appeared first…